Connect with us

Local News

Second case of rare blood clots identified | The Transcontinental



Australia’s medicine regulator has identified a second case of rare blood clots believed to be linked to the AstraZeneca vaccine.

The Therapeutic Goods Administration released a safety alert announcing the possible link on Tuesday.

The blood clots affected a woman aged in her 40s who was vaccinated in Western Australia.

“The person remains in hospital receiving treatment and is in a stable condition,” the regulator said.

The rare but potentially deadly blood-clotting disorder recently resulted in the AstraZeneca vaccine being no longer recommended to any Australians aged under 50, derailing the national vaccine rollout.

It is the second Australian report of a case of rare blood clots after a 44-year-old Melbourne man developed the condition…

Click here to view the original article.

Continue Reading

You might also like ...

Australia remains in a climate transition muddle | The Transcontinental
Round 6 Statewide Super League Teams